Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit

Effects on the Emergence and Transmission of Vancomycin-Resistant Enterococci After Changes in Antibiotic Use in a Hematology Unit.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00167960

Enrollment

1500

Registered

2005-09-14

Start date

2005-01-31

Completion date

Unknown

Last updated

2007-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gram-Positive Bacterial Infections

Keywords

Bacterial Infections

Brief summary

To determine the impact of the restriction of the third and forth generation cephalosporins on the reduction of intestinal colonization or infection with vancomycin-resistant enterococci (VRE) in a surgical intensive care unit (SICU)

Interventions

DRUGPiperacillin/tazobactam and other β-lactam/β-lactamase

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All patients admitted to or transferred to the SICU. * Eligible patients will be patients of either sex, 18 years of age or older who are admitted or transferred to the SICU. * Provide written informed consent

Exclusion criteria

* Patients who have hypersensitivity to penicillin, cephalosporins or beta-lactamase inhibitors. * Females who are pregnant and breast feeding * Any underlying conditions or non-infectious diseases that will be ultimately fatal within 48 hours. * Those who have already been participating other clinical study related with antibiotics.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026